NEUROCRINE BIOSCIENCES INC

NBIX · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
154
SEC Filings

Business Summary

PARTI Overview Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing, and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine, and immunological disorders. Our portfolio of products includes U.S. Food and Drug Administration (FDA) approved treatments for tardive dyskinesia (TD), chorea associated wit...

Next Earnings

Q2 FY2026 — expected 2026-07-28

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionNBIXdiscussed_in_filing Cybersecurity
topic_mentionNBIXdiscussed_in_filing Trusted Computing
topic_mentionNBIXdiscussed_in_filing Blockchain & Crypto
topic_mentionNBIXdiscussed_in_filing Regulation
topic_mentionNBIXdiscussed_in_filing Healthcare & Bio
topic_mentionNBIXdiscussed_in_filing Platform & Ecosystem
topic_mentionNBIXdiscussed_in_filing Sovereign & Government
topic_mentionNBIXdiscussed_in_filing Cybersecurity
topic_mentionNBIXdiscussed_in_filing Trusted Computing
topic_mentionNBIXdiscussed_in_filing Blockchain & Crypto
topic_mentionNBIXdiscussed_in_filing Regulation
topic_mentionNBIXdiscussed_in_filing Healthcare & Bio
topic_mentionNBIXdiscussed_in_filing Platform & Ecosystem
topic_mentionNBIXdiscussed_in_filing Sovereign & Government
topic_mentionNBIXdiscussed_in_filing Cybersecurity
topic_mentionNBIXdiscussed_in_filing Trusted Computing
topic_mentionNBIXdiscussed_in_filing Blockchain & Crypto
topic_mentionNBIXdiscussed_in_filing Regulation
topic_mentionNBIXdiscussed_in_filing Healthcare & Bio
topic_mentionNBIXdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-112025-12-310000914475-26-000007EDGAR65K words
2025-02-102024-12-310000914475-25-000037EDGAR—
2024-02-092023-12-310000914475-24-000054EDGAR—
2023-02-092022-12-310000914475-23-000011EDGAR—
2022-02-112021-12-310000914475-22-000013EDGAR—
2021-02-052020-12-310000914475-21-000020EDGAR—
2020-02-072019-12-310001564590-20-003773EDGAR—
2019-02-082018-12-310001564590-19-002328EDGAR—
2018-02-132017-12-310001193125-18-042794EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-282025-09-300000914475-25-000181EDGAR38K words
2025-07-302025-06-300000914475-25-000158EDGAR—
2025-05-052025-03-310000914475-25-000100EDGAR—
2024-10-302024-09-300000914475-24-000211EDGAR—
2024-08-012024-06-300000914475-24-000181EDGAR—
2024-05-012024-03-310000914475-24-000117EDGAR—
2023-10-312023-09-300000914475-23-000073EDGAR—
2023-08-012023-06-300000914475-23-000057EDGAR—
2023-05-032023-03-310000914475-23-000044EDGAR—
2022-11-012022-09-300000914475-22-000058EDGAR—
2022-08-042022-06-300000914475-22-000044EDGAR—
2022-05-042022-03-310000914475-22-000022EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-060001193125-26-142904EDGAR67K words
2026-02-110000914475-26-000006EDGAR—
2025-11-240000914475-25-000186EDGAR—
2025-10-280000914475-25-000180EDGAR—
2025-07-300000914475-25-000157EDGAR—
2025-05-300000914475-25-000139EDGAR—
2025-05-220000914475-25-000120EDGAR—
2025-05-050000914475-25-000099EDGAR—
2025-04-040000914475-25-000081EDGAR—
2025-02-060000914475-25-000034EDGAR—

154 total filings indexed. 123 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0000914475
TickerNBIX
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 7247e2b246ac40ecd328bbc1e1a90f9bfaeda927043f75f6f8d729b5caf02cfa
parent: d80d3ea391e0aaeb3e036e394266b4710e57a69c8e113e7b841d03fdba9a486a
content hash: 041d5122254daa8f0937c5c17b51d4a98a9346104ac69bda9b219425a5a74da0
signed: 2026-04-13T04:46:26.698Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf